Form 483

A&Z Pharmaceutical Inc Form 483, 2017-11-22

FDA issued a Form 483 to A&Z Pharmaceutical Inc on 2017-11-22 with 6 public-safe observations.

483· Form 483 issuedHuman Drugs6 observations

A&Z Pharmaceutical Inc · Hauppauge, United States · Issued November 22, 2017

Overview

  • 6 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

22 Nov 2017
21 CFR 211.68(a)

Calibration/Inspection/Checking not done

Cited by Jay T Wong, Alice S Tsao

22 Nov 2017
21 CFR 211.142

Written warehousing procedures established/followed

Cited by Jay T Wong, Alice S Tsao

22 Nov 2017
21 CFR 211.166(a)

Written program not followed

Cited by Jay T Wong, Alice S Tsao

22 Nov 2017
21 CFR 211.170(b)

Annual visual exams of drug products

Cited by Jay T Wong, Alice S Tsao

22 Nov 2017
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Jay T Wong, Alice S Tsao

Inspected site

APA&Z Pharmaceutical IncHauppauge, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.142Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x
21 CFR 211.170(b)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.208Cited across public-safe Form 483 observations1x
21 CFR 211.68(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 6 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere